Effect of neutral endopeptidase 24.11 Inhibition on myocardial ischemia/reperfusion injury: The role of kinins

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 2, 1997, Pages 250-256

  Yang, Xiao Ping ^a   Liu, Yun He ^a   Peterson, Edward ^a   Carretero, Oscar A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Atrial natriuretic peptide; Ischemia reperfusion; Kinin antagonist; Kinins; Myocardial infarction; NEP 24.11

Indexed keywords

ATRIAL NATRIURETIC FACTOR ANTAGONIST; CGS 24592; HS 142 1; ICATIBANT; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE INHIBITOR; RAMIPRILAT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CORONARY ARTERY OBSTRUCTION; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; KALLIKREIN KININ SYSTEM; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; BLOOD PRESSURE; KININS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NEPRILYSIN; PHENYLALANINE; PHOSPHONIC ACIDS; POLYSACCHARIDES; PROTEASE INHIBITORS; RATS; RATS, INBRED LEW;

EID: 0031029540     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199702000-00014     Document Type: Article

References (31)

1. Braun E, Kloner RA. Myocardial reperfusion: a double-edged sword? J Clin Invest 1985;76:1713-9.
2. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol 1990;52:561-76.
3. Muller DWM, Topol EJ, Califf RM, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Am Heart J 1990; 119:224-31.
4. Bolli R. Mechanism of myocardial "stunning." Circulation 1990; 82:723-38.
5. Lefer AM, Tsao PS, Lefer DJ, Ma X-L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991;5:2029-34.
6. Go LO, Murry CE, Richard VJ, Weischedel GR, Jennings RB, Reimer KA. Myocardial neutrophil accumulation during reperfusion after reversible and irreversible ischemic injury. Am J Physiol 1988;255:H1188-98.
7. Potter GD, Lester R, Burlingame SM, Mitchell PA, Schmidt KL. Taurodeoxycholate and the developing rabbit distal colon: absence of secretory effect. Am J Physiol 1987;253:G483-8.
8. Liu Y-H, Yang X-P, Sharov VG, Sigmon DH, Sabbah HN, Carretero OA. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996;27:7-13.
9. Parratt JR. Cardioprotection by angiotensin converting enzyme inhibitors: the experimental evidence. Cardiovasc Res 1994;28:183-9.
10. Rochette L, Ribuot C, Belichard P, Bril A, Devissaguet M. Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat. Clin Exp Hypertens [A] 1987;9:365-8.
11. Linz W, Martorana PA, Grötsch H, Bei-Yin Q, Schölkens BA. Antagonizing bradykinin (BK) obliterates the cardioprotective effects of bradykinin and angiotensin-converting enzyme (ACE) inhibitors in ischemic hearts. Drug Dev Res 1990;19:393-408.
12. Noda K, Sasaguri M, Ideishi M, Ikeda M, Arakawa K. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 1993;27:334-40.
13. Ishida H, Scicli AG, Carretero OA. Contributions of various rat plasma peptidases to kinin hydrolysis. J Pharmacol Exp Ther 1989; 251:817-20.
14. Ishida H, Scicli AG, Carretero OA. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins. Hypertension 1989;14:322-7.
15. Pelc LR, Gross GJ, Warltier DC. Mechanism of coronary vasodilation produced by bradykinin. Circulation 1991;83:2048-56.
16. Nolly H, Carbini LA, Scicli G, Carretero OA, Scicli AG. A local kallikrein-kinin system is present in rat hearts. Hypertension 1994;23:919-23.
17. Trippodo NC, Fox M, Natarajan V, Panchal BC, Dorso CR, Asaad MM. Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure. J Pharmacol Exp Ther 1993;267:108-16.
18. Piedimonte G, Nadel JA, Long CS, Hoffman JIE. Neutral endopeptidase in the heart: neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation. Circ Res 1994;75:770-9.
19. Liu Y-H, Xang X-P, Nass O, Sabbah HN, Peterson E, Carretero OA. Chronic cardiac failure induced by coronary artery ligation in Lewis inbred rats. Am J Physiol (in press).
20. Yang X-P, Sabbah HN, Liu Y-H, et al. Ventriculographic evaluation in three rat models of cardiac dysfunction. Am J Physiol 1993; 266:H1946-52.
21. Kerr MA, Kenny AJ. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem J 1974; 137:477-88.
22. Gee NS, Bowes MA, Buck P, Kenny AJ. An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem J 1985;228:119-26.
23. Erdös EG, Skidgel RA. Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J 1989; 3:145-51.
24. Sybertz EJ Jr, Chiu PJS, Watkins RW, Vemulapalli S. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action. Can J Physiol Pharmacol 1991;69:1628-35.
25. Ura N, Carretero OA, Erdös EG. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int 1987;32:507-13.
26. Smits GJ, McGraw DE, Trapani AJ. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects. Am J Physiol 1990;258:F1417-24.
27. Graf K, Koehne P, Gräfe M, Zhang M, Auch-Schwelk W, Fleck E. Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension 1995;26:230-5.
28. Maxwell AJ, Husseini WK, Piedimonte G, Hoffman JIE. Effects of inhibiting neutral endopeptidase and kininase II on coronary and systemic hemodynamics in rats. Am J Physiol 1995;269:H1016-29.
29. Hartman JC, Wall TM, Hullinger TG, Shebuski RJ. Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140. J Cardiovasc Pharmacol 1993; 21:996-1003.
30. Monta E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91.
31. Sano T, Morishita Y, Matsuda Y, Yamada K. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. J Pharmacol Exp Ther 1992;260:825-31.